Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study

PURPOSE: To evaluate the effectiveness and safety of the optimal tocilizumab dosing regimen. METHODS: A two-center, retrospective cohort study, for COVID19 critically ill patients admitted to the intensive care units (ICUs). We included critically ill patients aged 18 years or older who received toc...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Sulaiman, Khalid, Aljuhani, Ohoud, Bin Salah, Khalid, Korayem, Ghazwa B., Eljaaly, Khalid, Al Essa, Mohammed, Kharbosh, Abdullah, Al Harbi, Feras, Abuzaid, Maram, Al Bilal, Sarah, Almagthali, Alaa, Alsohemi, Samia, Alshabasy, Adel, Noureldeen, Haytham, Aboudeif, Mohammed, Alshehri, Asma, Vishwakarma, Ramesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381723/
https://www.ncbi.nlm.nih.gov/pubmed/34438133
http://dx.doi.org/10.1016/j.jcrc.2021.08.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381723/
https://www.ncbi.nlm.nih.gov/pubmed/34438133
http://dx.doi.org/10.1016/j.jcrc.2021.08.007

Ejemplares similares